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Abstract: (1) Background: Paraoxonase 2 (PON2) is a ubiquitously expressed protein localized
to endoplasmic reticulum and mitochondria. Previous studies have shown that PON2 exhibits
anti-oxidant and anti-inflammatory functions, and PON2-deficient (PON2-def) mice are more
susceptible to atherosclerosis. Furthermore, PON2 deficiency leads to impaired mitochondrial
function. (2) Methods: In this study, we examined the susceptibility of PON2-def mice to diet-induced
obesity. (3) Results: After feeding of an obesifying diet, the PON2-def mice exhibited significantly
increased body weight due to increased fat mass weight as compared to the wild-type (WT) mice.
The increased adiposity was due, in part, to increased adipocyte hypertrophy. PON2-def mice
had increased fasting insulin levels and impaired glucose tolerance after diet-induced obesity.
PON2-def mice had decreased oxygen consumption and energy expenditure. Furthermore, the
oxygen consumption rate of subcutaneous fat pads from PON2-def mice was lower compared to WT
mice. Gene expression analysis of the subcutaneous fat pads revealed decreased expression levels of
markers for beige adipocytes in PON2-def mice. (4) Conclusions: We concluded that altered systemic
energy balance, perhaps due to decreased beige adipocytes and mitochondrial dysfunction in white
adipose tissue of PON2-def mice, leads to increased obesity in these mice.
Keywords: obesity; mitochondrial function; antioxidant
1. Introduction
Obesity is caused by an excess accumulation of body fat resulting from an imbalance between
energy intake and energy expenditure. The incidence of obesity has been rising in the United States and
worldwide [1]. Obesity is a risk factor for cardiovascular disease, diabetes, hypertension, and certain
types of cancer [1]. In contrast to white adipose tissue (WAT), brown adipose tissue (BAT) dissipates
energy by heat generation through UCP1. Upon cold exposure or treatment with β-3 adrenergic agonists,
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some adipocytes in the WAT called brite or beige adipocytes can acquire brown adipocyte-like features
such as increased UCP1 expression [2,3]. Several secretory factors such as catecholamines, FGF21, and
irisin have been shown to promote beiging of WAT [3]. Enhanced WAT beiging/browning leads to
increased energy expenditure and decreased obesity in both mouse and human studies [4,5]. Interestingly,
endoplasmic reticulum (ER) stress-induced mitochondria dysfunction appears to attenuate thermogenic
activation/browning of subcutaneous WAT in mice [6], suggesting that ER stress may prevent white to
beige conversion and promote obesity.
Furthermore, obesity is associated with adipocyte mitochondrial dysfunction in animal models
and humans [7–9]. Recent studies have demonstrated a causal relationship between mitochondrial
dysfunction and obesity in mice and humans [10,11]. In mice, age-dependent mitochondrial complex
IV dysfunction due to loss of essential complex IV components such as Cox5b in white adipocytes led
to decreased fatty acid oxidation, increased lipid accumulation, and obesity [10]. In vivo, silencing of
Cox5b in the white adipose tissue of young mice led to adipocyte hypertrophy whereas restoration
of Cox5b expression led to decreased adipocyte size in aging mice [10]. These findings suggest
an important role of mitochondrial complex IV in aging-associated obesity. In humans, specific
mutations of the mitofusin 2, a membrane-bound mediator of mitochondrial membrane fusion and
inter-organelle communication, caused white adipose tissue mitochondrial dysfunction with increased
adipocyte proliferation and survival, leading to obesity [11]. Furthermore, oxidative stress is known to
cause mitochondrial dysfunction and metabolic disorders such as insulin resistance and obesity [12,13].
Overexpression of ALCAT1, a lyso-cardiolipin (CL) acyltransferase upregulated by oxidative stress and
diet-induced obesity (DIO), increased the synthesis of CL species that are highly sensitive to oxidative
damage, leading to mitochondrial dysfunction, reactive oxygen species (ROS) production, and insulin
resistance [12]. In contrast, ALCAT1 deficiency prevented the onset of DIO and significantly improved
mitochondrial complex I activity, fatty acid oxidation, and insulin signaling in ALCAT1−/− mice [12].
These data demonstrated that increased ROS production can lead to mitochondrial dysfunction
and obesity.
Paraoxonase 2 belongs to the paraoxonase gene family. PON2 is ubiquitously expressed and has been
localized to nuclear envelope, endoplasmic reticulum, and mitochondria [14,15]. Within the mitochondria,
PON2 appears to be localized at the inner mitochondrial membrane where it associates with complex III
of the electron transport chain [14]. Overexpression of PON2 in cells prevents ER stress, mitochondrial
superoxide formation, cardiolipin peroxidation, and apoptosis [16–18], whereas knocking down PON2
level in cells leads to increased ER stress [19]. Previously, we demonstrated that PON2 deficiency in mice
leads to increased atherosclerosis due to decreased anti-oxidative and anti-inflammatory capacity [14,20].
PON2 deficiency is associated with impaired mitochondrial aerobic respiration and elevated levels of
reactive oxygen species (ROS) in the macrophages [14] and decreased complex I + III activity and increased
mitochondrial superoxide level in the liver [14]. In this report, we demonstrated that PON2-def mice are
more susceptible to diet-induced obesity. The underlying mechanisms are explored.
2. Materials and Methods
2.1. Mice and Diet
All animal experiments were approved by the UCLA Animal Care and Use Committee,
in accordance with PHS guidelines. The protocol number is ARC # 1992–169 (Approval Period
from 6/6/2016 through 11/25/2018). The mice used for the study were derived originally from the
offspring of PON2 heterozygous mice intercross. PON2-def mice that resulted from the intercross were
used to establish the PON2-def colony, whereas wild-type (WT) mice that resulted from the intercross
were used to establish the WT colony. Two-month-old female PON2-def and wild-type (WT) mice were
fed an obesifying diet (D12266B, Research Diets) for 8 weeks and fasted overnight before blood and
tissue collection. Two cohorts of mice were investigated in this study. The overview of experimental
procedures is shown in Supplemental Figure S1. For the obesity experiment presented in Figure 1
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and Table 1, 10 mice per genotype group were used (Cohort #1). This was based on power/sample
size calculation assuming a 40% difference in body weight between the two groups of mice, common
standard deviation: 30%, type I error rate: 0.05, and power: 0.8. For data presented in Figures 2 and 3,
a separate cohort (cohort #2, Supplemental Figure S1) was used.
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However, when placed on a high fat, high sucrose obesifying diet, the PON2-def mice weighed 
significantly more at 2, 4, and 8 weeks after feeding of the obesifying diet (Figure 1A). PON2-def mice 
gained significantly more fat mass but the same amount of lean mass as compared to the WT mice 
after 8-week feeding (Figure 1B). PON2-def mice exhibited significantly increased adiposity as 
expressed by both % fat mass/body weight and % weight of four major fat pads/body weight (Figure 
1C). The gonadal and subcutaneous fat pads of the PON2-def mice were significantly larger as 
compared to those of the WT mice (p < 0.05 for both fat pads, data not shown), whereas the mesenteric 
and retroperitoneal fat pads of the PON2-def mice showed a trend of increased weights (p = 0.06 and 
p = 0.08, respectively, data not shown) as compared to those of the WT mice. The mean adipocyte size 
and weight, but not adipocyte number, of subcutaneous fat pads of the PON2-def mice were 
significantly increased as compared to those of the WT mice (Figure 1D), suggesting that adipocyte 
hypertrophy can explain, in part, the increased obesity observed in the PON2-def mice. There are no 
significant differences in plasma levels of triglyceride, total cholesterol, HDL cholesterol, free fatty 
acid, and glucose between the WT and PON2-def mice (Table 1). However, the fasting insulin levels 
of the PON2-def mice after 8 weeks of diet feeding were significantly increased as compared to those 
of the WT mice (Table 1, p < 0.05). Glucose tolerance test revealed that PON2-def mice had 
significantly increased blood glucose levels at 60 min, and 120 min after receiving 1g/kg dose of 
glucose as compared to the WT mice (Figure 1E). The mean area under the curve (AUC) from the 
IPGTT of the PON2-def mice was significantly increased as compared to the WT mice (Figure 1F), 
suggesting glucose intolerance in the PON2-def mice.   
 
Figure 1. PON2-deficient (PON2-def) mice are more prone to diet-induced obesity and exhibit glucose 
intolerance. (A) to (D) Two-month-old female PON2-def and wild-type (WT) mice (n = 10 for each 
group) were fed an obesifying diet for 8 weeks before sacrifice. (A) Body weights of mice at baseline 
(week 0), 2, 4, 6, and 8 weeks after the start of obesifying diet feeding are shown. (B) Changes in Fat 
or lean mass after 8 week-feeding of the obesifying diet are shown. (C) Total fat mass and weight of 
four fat pads (gonadal, mesenteric, retroperitoneal, and subcutaneous fat pads), expressed as % of 
body weight, at sacrifice are shown. (D) The mean adipocyte size, weight, and number of 
subcutaneous fat pads are shown. (E) Glucose tolerance test data of WT and PON2-def mice fed the 
obesifying diet for 7 weeks are shown. (F) Mean AUC data of IPGTT are shown. *: p < 0.05 vs. WT 
group. 
  
Figure 1. PON2-deficient (PON2-def) mice are more prone to diet-induced obesity and exhibit glucose
intolerance. (A) to (D) Two-month-old female PON2-def and wild-type (WT) mice (n = 10 for each
group) were fed an obesifying diet for 8 weeks before sacrifice. (A) Body weights of mice at baseline
(week 0), 2, 4, 6, and 8 weeks after the start of obesifying diet feeding are shown. (B) Changes in Fat or
lean mass after 8 week-feeding of the obesifying diet are shown. (C) Total fat mass and weight of four
fat pads (gonadal, mesenteric, retroperitoneal, and subcutaneous fat pads), expressed as % of body
weight, at sacrifice are shown. (D) The mean adipocyte size, weight, and number of subcutaneous fat
pads are shown. (E) Glucose tolerance test data of WT and PON2-def mice fed the obesifying diet for
7 weeks are shown. (F) Mean AUC data of IPGTT are shown. *: p < 0.05 vs. WT group.
Table 1. Plasma lipid, glucose, and insulin levels of WT and PON2-def mice fed the obesifying diet for
8 weeks.
Genotype n Triglyceride Total Chol. HDL Chol. VLDL/IDL/LDLChol.
Unesterified
Chol. Free Fatty Acid Glucose Insulin
WT 9 35 (7) 128 (5) 91 (4) 47 (12) 18 (1) 48 (3) 143 (10) 336 (48)
PON2KO 10 34 (8) 118 (17) 87 (13) 30 (6) 19 (2) 47 (3) 147 (8) 485 (47)
p value 0.91 0.58 0.80 0.20 0.63 0.76 0.71 0.04
Values shown are means and (standard errors). Units are mg/dL except insulin which is shown in
pg/mL. Abbreviations: Chol.: cholesterol, VLDL/IDL/LDL: very low density lipoprotein/intermediate density
lipoprotein/low density lipoprotein.
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Figure 2. PON2-def mice exhibit altered metabolic phenotypes as compared to the WT mice. Two-
month-old female PON2-def and wild-type (WT) mice were fed an obesifying diet for 2 weeks before 
they were placed individually in metabolic chambers for 3 days to measure metabolic parameters 
including (A, B) oxygen consumption rate, (C, D) CO2 production rate, (E, F) energy expenditure 
(EE), (G) food intake, and (H) activity. n = 6 for each group. 12-hr light/dark cycles; 72-hr total 
duration; and each light/dark bar represents 12 hr duration. After 8 hr of acclimation, data from the 
last 64 hr of the 72 hr experiment were used for data analysis. #: p < 0.07, *: p < 0.05, vs. WT group. 
Figure 2. PON2-def mice exhibit altered metabolic phenotypes as compared to the WT mice.
Two-month-old female PON2-def and wild-type (WT) mice were fed an obesifying diet for 2 weeks
before they were placed individually in metabolic chambers for 3 days to measure metabolic parameters
including (A,B) oxygen consumption rate, (C,D) CO2 production rate, (E,F) energy expenditure (EE),
(G) food intake, and (H) activity. n = 6 for each group. 12-h light/dark cycles; 72-h total duration; and
each light/dark bar represents 12 h duration. After 8 h of acclimation, data from the last 64 h of the
72 h experiment were used for data analysis. #: p < 0.07, *: p < 0.05, vs. WT group.
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periods (Figure 2H). We then investigated the oxygen consumption rates of tissues collected from the 
PON2-def and WT mice. The oxygen consumption rate of subcutaneous fat pads isolated from the 
PON2-def mice was more than 50% lower as compared to those of the WT mice (Figure 3A). On the 
other hand, no significant differences were observed in oxygen consumption rates between the brown 
adipose tissues and gastrocnemius muscles of PON2-def and WT mice (Figure 3A). 
 
Figure 3. White adipose tissue collected from the PON2-def mice exhibited a decreased oxygen 
consumption rate and decreased mRNA levels of gene markers for beige adipocytes. (A) Relative 
oxygen consumption rates of subcutaneous fat pads (WAT), brown adipose tissue (BAT) and 
gastrocnemius muscle (GM) isolated from mice fed the obesifying diet for 8 weeks are shown. n = 6 
for each group. Gene expression analyses of subcutaneous fat pads (B), and BAT (C) collected from 
mice fed the obesifying diet are shown. n = 6 for each group. #: p = 0.085, *: p < 0.05, vs. WT group. 
3.3. Gene Expression Analysis of WAT and BAT 
Enhanced WAT beiging leads to increased energy expenditure and decreased obesity in both 
mouse and human studies [4,5]. We hypothesized that the increased obesity observed in the PON2-
def mice might be partly due to decreased beiging of WAT. Gene expression analysis of the 
subcutaneous WAT showed that the expression levels of beige adipocyte gene markers including 
Cidea, Pgc1a, Prdm16, and Ucp1 were significantly decreased by more than 50% in the PON2-def as 
compared to those of the WT mice (Figure 3B), providing evidence that PON2 deficiency is associated 
with deceased beiging of WAT. In contrast, the expression levels of characteristic brown fat genes 
including Cidea, Elovl3, Pgc1a, and Ucp1 in the BAT of PON2-def and WT mice were similar (Figure 
3C).  
4. Conclusion 
Our study demonstrated that PON2 deficiency leads to increased DIO and impaired glucose 
tolerance in mice. The PON2-def mice exhibited decreased energy expenditure and oxygen 
consumption with no change in food consumption as compared to the WT mice, suggesting that 
decreased energy expenditure may be the underlying cause of obesity observed in the PON2-def 
mice. The oxygen consumption rate of the subcutaneous WAT isolated from the PON2-def mice was 
significantly decreased as compared to the WT mice. Furthermore, the expression of beige cell gene 
markers was significantly lower in the subcutaneous WAT of PON2-def mice. These findings suggest 
Figure 3. White adipose tissue collected from the PON2-def mice exhibited a decreased oxygen
consumption rate and decreased mRNA levels of gene markers for beige adipocytes. (A) Relative
oxygen consumption rates of subcutaneous fat pads (WAT), brown adipose tissue (BAT) and
gastrocnemius muscle (GM) isolated from mice fed the obesifying diet for 8 weeks are shown. n = 6 for
each group. Gene expression analyses of subcutaneous fat pads (B), and BAT (C) collected from mice
fed the obesifying diet are shown. n = 6 for each group. #: p = 0.085, *: p < 0.05, vs. T group.
2.2. Plasma Lipids, Glucose, and Insulin Assays
Plasma triglyceride, total cholesterol, high density lipoprotein (HDL) cholesterol, free fatty acid,
and glucose levels were measured by colorimetric assays as previously described [21]. Plasma insulin
levels were measured by ELISA using kits purchased from ALPCO (Salem, NH, USA).
2.3. Body Composition by Quantitative Nuclear Magnetic Resonance
Animals were measured for total body fat mass and lean m ss by nuclear magnetic resonance
(NMR) using the Bruker Minispec with software from Echo Medical Systems (Houston, TX, USA) [22].
2.4. Glucose Tolerance Test
Mice were fed the obesifying diet for 7 weeks before intraperitoneal glucose tolerance tests
(IP-GTT, 1g glucose/kg body weight) were performed after 16-hour fasting [23]. Area under the curve
was calculated using Prism 5 (GraphPad Software Inc., La Jolla, CA, USA)
2.5. Metab lic Chamber Study
Mice were fed the obesifying diet for 2 weeks before metabolic chamber study was performed
using a Columbus Instruments Comprehensive Lab Animal Monitoring System (Columbus Instruments
International, Columbus, OH, USA) as previously described [24].
2.6. Oxygen Consumption Study
The oxygen consumption rate of tissue was determined using an XF24–3 Extracellular Flux
Analyzer (Seahorse Bioscience, Billerica, MA, USA) as described [21].
2.7. RNA Isolation and Quantitative RT-PCR Analyses
Total RNA samples from tissues were isolated using Trizol reagent (Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s protocol. The cDNA was synthesized using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Quantitative
PCR was performed using gene-specific primers (Supplemental Table S1) and the Roche SYBR green
master mix in a Roche Lightcycler 480 system (Roche, Indianapolis, IN, USA). The mRNA levels
of specific genes were normalized to the mRNA levels of the housekeeping gene, Rpl13a, of the
same sample.
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2.8. Determination of Average Adipocyte Size and Adipose Cell Number
H & E stained histological sections of subcutaneous fat pads were used for determination of
adipocyte size as previously described [25]. Determination of adipocyte number was performed as
described [26].
2.9. Statistical Analysis
Two tailed, unpaired Student’s t test, available in Prism 5 (GraphPad Software Inc., La Jolla, CA,
USA), was used for statistical analysis to compare group means between the WT and PON2-def mice.
3. Results and Discussion
3.1. PON2-def Mice Are More Susceptible to Diet-Induced Obesity and Exhibit Glucose Intolerance
Female PON2-def mice exhibited similar body weight (Figure 1A) and adiposity (as judged
by % fat mass/body weight, data not shown) as compared to the age and sex matched wild-type
mice. However, when placed on a high fat, high sucrose obesifying diet, the PON2-def mice weighed
significantly more at 2, 4, and 8 weeks after feeding of the obesifying diet (Figure 1A). PON2-def
mice gained significantly more fat mass but the same amount of lean mass as compared to the WT
mice after 8-week feeding (Figure 1B). PON2-def mice exhibited significantly increased adiposity
as expressed by both % fat mass/body weight and % weight of four major fat pads/body weight
(Figure 1C). The gonadal and subcutaneous fat pads of the PON2-def mice were significantly larger as
compared to those of the WT mice (p < 0.05 for both fat pads, data not shown), whereas the mesenteric
and retroperitoneal fat pads of the PON2-def mice showed a trend of increased weights (p = 0.06 and
p = 0.08, respectively, data not shown) as compared to those of the WT mice. The mean adipocyte
size and weight, but not adipocyte number, of subcutaneous fat pads of the PON2-def mice were
significantly increased as compared to those of the WT mice (Figure 1D), suggesting that adipocyte
hypertrophy can explain, in part, the increased obesity observed in the PON2-def mice. There are no
significant differences in plasma levels of triglyceride, total cholesterol, HDL cholesterol, free fatty
acid, and glucose between the WT and PON2-def mice (Table 1). However, the fasting insulin levels
of the PON2-def mice after 8 weeks of diet feeding were significantly increased as compared to
those of the WT mice (Table 1, p < 0.05). Glucose tolerance test revealed that PON2-def mice had
significantly increased blood glucose levels at 60 min, and 120 min after receiving 1g/kg dose of
glucose as compared to the WT mice (Figure 1E). The mean area under the curve (AUC) from the
IPGTT of the PON2-def mice was significantly increased as compared to the WT mice (Figure 1F),
suggesting glucose intolerance in the PON2-def mice.
3.2. PON2-def Mice Exhibit Altered Systemic Energy Balance and a Decreased Oxygen Consumption Rate in
the White Adipose Tissue
Metabolic chamber study showed that PON2-def mice exhibited a significantly decreased oxygen
consumption rate (OCR) in the light period and a trend of decreased OCR in the dark period as
compared to the WT mice (Figure 2A,B). The CO2 production rates of the PON2-def in both the light
and dark periods were significantly decreased (Figure 2C,D) as compared to the WT mice. Interestingly,
PON2-def mice showed significantly decreased energy expenditure during both light and dark periods
as compared to the WT mice (Figure 2E,F). The food intake was similar between the two groups of
mice (Figure 2G). Furthermore, PON2-def mice were less active during the dark periods (Figure 2H).
We then investigated the oxygen consumption rates of tissues collected from the PON2-def and WT
mice. The oxygen consumption rate of subcutaneous fat pads isolated from the PON2-def mice
was more than 50% lower as compared to those of the WT mice (Figure 3A). On the other hand,
no significant differences were observed in oxygen consumption rates between the brown adipose
tissues and gastrocnemius muscles of PON2-def and WT mice (Figure 3A).
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3.3. Gene Expression Analysis of WAT and BAT
Enhanced WAT beiging leads to increased energy expenditure and decreased obesity in both
mouse and human studies [4,5]. We hypothesized that the increased obesity observed in the PON2-def
mice might be partly due to decreased beiging of WAT. Gene expression analysis of the subcutaneous
WAT showed that the expression levels of beige adipocyte gene markers including Cidea, Pgc1a,
Prdm16, and Ucp1 were significantly decreased by more than 50% in the PON2-def as compared to
those of the WT mice (Figure 3B), providing evidence that PON2 deficiency is associated with deceased
beiging of WAT. In contrast, the expression levels of characteristic brown fat genes including Cidea,
Elovl3, Pgc1a, and Ucp1 in the BAT of PON2-def and WT mice were similar (Figure 3C).
4. Conclusions
Our study demonstrated that PON2 deficiency leads to increased DIO and impaired glucose
tolerance in mice. The PON2-def mice exhibited decreased energy expenditure and oxygen
consumption with no change in food consumption as compared to the WT mice, suggesting that
decreased energy expenditure may be the underlying cause of obesity observed in the PON2-def
mice. The oxygen consumption rate of the subcutaneous WAT isolated from the PON2-def mice was
significantly decreased as compared to the WT mice. Furthermore, the expression of beige cell gene
markers was significantly lower in the subcutaneous WAT of PON2-def mice. These findings suggest
that decreased beige adipocyte number and impaired mitochondrial function may contribute to the
increased DIO associated with PON2 deficiency. Previous studies have demonstrated that PON2
plays an important role in preventing ER stress, mitochondrial superoxide formation, cardiolipin
peroxidation, and apoptosis in cultured cells [16–19]. In agreement, our groups have shown that PON2
deficiency was associated with impaired mitochondrial aerobic respiration and elevated levels of
reactive oxygen species (ROS) in macrophages [14] and decreased complex I + III activity and increased
mitochondrial superoxide level in the livers [14] of PON2-def mice. Therefore, we conclude that the
increased ER stress and mitochondrial dysfunction associated with PON2 deficiency are likely the
underlying mechanisms leading to decreased beiging and energy expenditure, and increased adipocyte
hypertrophy and obesity observed in the PON2-def mice.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/8/1/19/s1,
Figure S1. Overview of the experimental procedures. Table S1. qPCR primers used in the study.
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